4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-023589
GENERAL COUNSEL & CORP SEC sold 22,117 shares at an average $20.11 ($444,809)
- GENERAL COUNSEL & CORP SEC acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-08-29 | Option exercise 10b5-1 | +850 | $7.07 | $6,010 | 24,798 | D: show line 1 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-08-29 | Sale 10b5-1 | −850 | $20.00 | $17,000 | 23,948 | D: show line 2 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-09-02 | Option exercise 10b5-1 | +9,150 | $7.07 | $64,691 | 33,098 | D: show line 3 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-09-02 | Sale 10b5-1 | −14,922 | $20.14 | $300,492 | 18,176 | D: show line 4 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-09-03 | Sale 10b5-1 | −6,345 | $20.07 | $127,317 | 11,831 | D: show line 5 in the form |
| Open-market sales · 22,117 sh · avg $20.11 · $444,809 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-08-29 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −850 | 24,951 | D: show line 6 in the form | ||
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2025-09-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,150 | 15,801 | D: show line 7 in the form |
Loading xslF345X05/form4-09032025_090917.xml…